Nanoliposomal irinotecan Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
Small-bowel Adenocarcinoma
Tiago Biachi de Castria36 enrolled6 locationsNCT06835387
Recruiting
Phase 2
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)
Metastatic Pancreatic Ductal Adenocarcinoma
Belgian Group of Digestive Oncology134 enrolled13 locationsNCT05472259